Aerie Pharmaceuticals (AERI) gained in the current market after announcing its fourth quarter and fiscal 2021 results. AERI values at $7.55, losing more than 27.97% compared to yesterday’s closing price. The stock closed at $5.9 at the end of the last trading session. The stock volume traded in the last trading session was around 799.65K shares. The current market cap of the company is around $346.66 million.
AERI: Q4 and Fiscal 2021 Key Financials
- Aerie Pharmaceuticals, Inc.’s revenue in Q4 2021 was $114.7 million. More than compared to the revenue of $24.27 million in Q4 2020.
- Fiscal year revenue was $194.1 million, more than compared to the revenue of $83.1 million in fiscal 2020.
- The company’s net income in Q4 2021 was around $45.5 million. Slightly less than the net income of $46.1 million in Q4 2020.
- AERI’s net loss in fiscal 2021 was around $74.8 million, improving its loss, compared to the net loss of $183.1 million in fiscal 2020.
- The Q4 2021 diluted earnings per share were $0.96. There was a loss per share of $1.00 in Q4 2020.
- For fiscal 2021, the diluted loss per share was $1.61, compared to the loss per share of $3.99 in fiscal 2020.
AERI CEO’ Remarks
CEO Raj Kannan said that he is excited to join Aerie at such an exciting moment in our development trend and announced that Aerie had a good year in 2021. We announced favorable Phase 2b findings on AR-15512 for dry eye, positive Phase 3 results on Rhopressa for glaucoma in Japan, finalized a second partnership deal with Santen. The company also maintained a healthy financial position. These accomplishments position Aerie for 2022 and onwards.
AERI 2022 Outlook
Aerie Pharmaceuticals, Inc. (AERI) anticipates $130 million to $140 million in 2022, representing a 16% t to 25% increase over the fiscal year 2021.
Even though AR-15512’s three Phase 3 trials have begun, Aerie Pharmaceuticals, Inc. (AERI) estimates a 15% decrease in total net cash consumed by 2022 compared to 2021, despite rising R&D and operational expenditures.
Conclusion
The company is growing at a fast pace and increasing its clientele. AERI is focused on the company’s growth and is not caring about profitability. In such strategies, profitability is the second phase after expansion and increasing market share.
